SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mitsui & Co. Ltd. – ‘4’ for 10/16/23 re: Thorne Healthtech, Inc.

On:  Tuesday, 10/17/23, at 4:15pm ET   ·   For:  10/16/23   ·   As:  10% Owner   ·   Accession #:  1209191-23-52958   ·   File #:  1-40826

Previous ‘4’:  ‘4’ on 9/29/21 for 9/27/21   ·   Latest ‘4’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/17/23  Mitsui & Co. Ltd.                 4          10% Owner   1:7K   Thorne Healthtech, Inc.           DONNELLEY FIN… File16/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Form 4 Submission -- doc4.xml/5.8                   HTML      8K 




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Form 4 Submission
 

The SEC has not released XSLT Stylesheets needed to render this File’s XML Data as a Form.

This is our “Plain Text” rendering:
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0508
Document Type:  4
Period of Report:  10/16/23
Not Subject to Section 16:  1
Issuer:
Issuer CIK:  1844280
Issuer Name:  Thorne Healthtech, Inc.
Issuer Trading Symbol:  THRN
Reporting Owner:
Reporting Owner ID:
Owner CIK:  67099
Owner Name:  MITSUI & CO LTD
Reporting Owner Address:
Owner Street 1:  2-1, OHTEMACHI 1-CHOME
Owner Street 2:
Owner City:  CHIYODA-KU TOKYO
Owner State:  M0
Owner ZIP Code:  100-8631
Owner State Description:  JAPAN
Reporting Owner Relationship:
Is Director?  No
Is Officer?  No
Is Ten Percent Owner?  Yes
Is Other?  No
Aff 10b5 One:  0
Non-Derivative Table:
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  10/16/23
Deemed Execution Date:
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  U
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  15,674,235
Transaction Price Per Share:
Footnote ID:  F1
Transaction Acquired-Disposed Code:
Value:  D
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Table:
Derivative Transaction:
Security Title:
Value:  Class A Common Stock Warrant (Right to buy)
Conversion or Exercise Price:
Value:  5.1237
Transaction Date:
Value:  10/16/23
Deemed Execution Date:
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  J
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  56,515
Transaction Price Per Share:
Footnote ID:  F2
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Footnote ID:  F2
Expiration Date:
Footnote ID:  F2
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  56,515
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Footnotes:
Footnote - F1This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 27, 2023, by and among Thorne HealthTech, Inc. (the "Issuer"), Healthspan Buyer, LLC, and Healthspan Merger Sub, Inc. ("Purchaser"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer ("Company Common Stock") and thereafter merged with and into the Issuer (the "Merger") effective as of October 16, 2023 (the "Effective Time"). At the Effective Time, each outstanding share of Company Common Stock was cancelled and converted into the right to receive $10.20 in cash (the "Offer Price"), without interest and subject to applicable withholding taxes.
Footnote - F2Pursuant to the Merger Agreement, at the Effective Time, each Class A Common Stock Warrant ("Company Warrant") held by the Reporting Person was automatically cancelled and converted into a right to receive an amount in cash, without interest, equal to the product of (A) the amount of the Offer Price (less the exercise price per share attributable to such Company Warrant) multiplied by (B) the total number of shares of Company Common Stock issuable upon exercise in full of such Company Warrant, subject to applicable withholding taxes.
Remarks:
Owner Signature:
Signature Name:  /s/ Mitsui & Co., LTD., by /s/ Yoshifumi Hatanaka, General Manager, NutriScience Division
Signature Date:  10/17/23


Top
Filing Submission 0001209191-23-052958   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 11:00:25.2am ET